Previous Page  39 / 63 Next Page
Information
Show Menu
Previous Page 39 / 63 Next Page
Page Background

Pamrevlumab: anti-CTGF (connective tissue growth factor) mAb

Resection 45% vs 17%

Carrier E, et al. ESMO 2017

1 … 34 35 36 37 38 39 40 41 42 43 44 45 … 63